Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Functional Neuromodulation Ltd.

www.functionalneuromodulation.com

Latest From Functional Neuromodulation Ltd.

Guidance Offers IDE Tips For Devices Targeting Brain Disease Progression

FDA issued a draft guidance to help device-makers conduct clinical trials for products designed to slow the progress of neurological conditions. One challenge highlighted by the agency is that changes to biomarkers measured in a study may not line up easily with disease progression.

Medical Device Clinical Trials

US Neurostimulation Devices Market Forecast to Grow By $1B+ With New Indications, New Technologies

The US neurostimulation technology market will grow nearly 46% over the next five years, according to a new report from Medtech Insight.

Medical Device Innovation

Top Device Research Payments: PARTNER II, Cardio, Neuro, Dx Device Trials Highest In 2014

The transcatheter aortic valve PARTNER II study, several stent trials, and studies looking at diagnostic tools and neurological devices dominated the top ten trials by total payment to clinical investigators in 2014, according to an analysis of CMS' Open Payments database.

Medical Device Regulation

Top Research Payments: PARTNER II, Cardio, Neuro, Dx Device Trials Highest In 2014

The transcatheter aortic valve PARTNER II study, several stent trials, and studies looking at diagnostic tools and neurological devices dominated the top ten trials by total payment to clinical investigators in 2014, according to a "Gray Sheet" analysis of CMS' Open Payments database.

Medical Device Regulation
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Functional Neuromodulation Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Functional Neuromodulation Ltd.
  • Senior Management
  • Vincent Owens, CEO
    Andres M Lozano, MD, PhD, Scientific Founder
    Todd Langevin, Pres. & COO
    Steve Targum, MD, Acting CMO
  • Contact Info
  • Functional Neuromodulation Ltd.
    Phone: (866) 296-4040
    2 Oliver St., Ste. 616
    Boston, MA 02109
    USA
UsernamePublicRestriction

Register